Drug profile · INN
calcitonin salmon recombinant
FORTICAL
calcitonin salmon recombinant (FORTICAL) is a calcitonin receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
Drug details — calcitonin salmon recombinant
- US status
- approved
- Class
- —
- Route
- NASAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
calcitonin salmon recombinant (FORTICAL) is a calcitonin receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
Key facts
Mechanism of action
Calcitonin receptor agonist
Primary target: Calcitonin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is calcitonin salmon recombinant?
calcitonin salmon recombinant (FORTICAL) is a calcitonin receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for calcitonin salmon recombinant?
FORTICAL is a marketed brand name for calcitonin salmon recombinant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of calcitonin salmon recombinant?
calcitonin salmon recombinant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.